HLS Therapeutics Inc
TSX:HLS

Watchlist Manager
HLS Therapeutics Inc Logo
HLS Therapeutics Inc
TSX:HLS
Watchlist
Price: 4.97 CAD 0.2%
Market Cap: 157.2m CAD
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one HLS stock under the Base Case scenario is 8.57 CAD. Compared to the current market price of 4.97 CAD, HLS Therapeutics Inc is Undervalued by 42%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

HLS Relative Value
Base Case
8.57 CAD
Undervaluation 42%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

2
P/S
P/S
Price to Sales
2
vs History
61
vs Industry
49
Median 3Y
1.8
Median 5Y
3.8
Industry
2.2
Forward
2
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-4.7
Median 5Y
-9.8
Industry
21.7
Forward
-12.3
More Details
10.7
P/OCF
P/OCF
Price to OCF
10.7
vs History
60
vs Industry
29
Median 3Y
9.8
Median 5Y
13.6
Industry
13.9
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
20
Median 3Y
14.2
Median 5Y
14.2
Industry
19.7
More Details
1.7
P/B
P/B
Price to Book Value
1.7
vs History
52
vs Industry
52
Median 3Y
1.2
Median 5Y
1.8
Industry
2.1
More Details
2.7
EV/S
EV/S
Enterprise Value to Sales
2.7
vs History
68
vs Industry
41
Median 3Y
2.7
Median 5Y
4.8
Industry
2.3
Forward
2.7
More Details
3.3
EV/GP
EV/GP
Enterprise Value to Gross Profit
3.3
vs History
61
vs Industry
58
Median 3Y
3.2
Median 5Y
5.2
Industry
4.8
More Details
8.9
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
8.9
vs History
80
vs Industry
31
Median 3Y
10
Median 5Y
14.1
Industry
11.4
Forward
7.9
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
Median 3Y
-14.2
Median 5Y
-31.4
Industry
15.4
Forward
-36.7
More Details
14.4
EV/OCF
EV/OCF
Enterprise Value to OCF
14.4
vs History
65
vs Industry
21
Median 3Y
14.1
Median 5Y
17.3
Industry
13.7
More Details
14.5
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
14.5
vs History
41
vs Industry
24
Median 3Y
14.2
Median 5Y
13.6
Industry
17.2
More Details
1.2
EV/IC
EV/IC
Enterprise Value to IC
1.2
vs History
55
vs Industry
55
Median 3Y
1
Median 5Y
1.4
Industry
1.8
More Details

Multiples Across Competitors

HLS Competitors Multiples
HLS Therapeutics Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
HLS Therapeutics Inc
TSX:HLS
157.7m CAD 2 -6.4 8.9 -33.5
US
Mckesson Corp
NYSE:MCK
90.2B USD 0.3 27.4 17.6 20.1
US
Amerisourcebergen Corp
LSE:0HF3
57.6B USD 0.2 34 14.6 19.7
US
Cencora Inc
NYSE:COR
56.9B USD 0.2 33.7 14.4 19.4
US
Cardinal Health Inc
NYSE:CAH
38.9B USD 0.2 25.2 13.5 17.8
AU
Sigma Healthcare Ltd
ASX:SIG
36.2B AUD 7.4 -2 618.6 1 678.6 1 678.6
CN
Huadong Medicine Co Ltd
SZSE:000963
72.8B CNY 1.7 20.4 16 16
CN
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
64.8B CNY 0.2 14.9 10.1 10.1
KR
Celltrion Healthcare Co Ltd
KOSDAQ:091990
12.2T KRW 5.9 89.6 59.9 61.9
US
Henry Schein Inc
NASDAQ:HSIC
8.8B USD 0.7 21.4 10.7 14.8
AU
EBOS Group Ltd
OTC:EBOSY
8.2B USD 1 51.2 30.6 30.6

See Also

Summary
HLS intrinsic value, competitors valuation, and company profile.
DCF Valuation
HLS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
HLS stock valuation using valuation multiples.
Wall Street Estimates
HLS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
HLS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 262,900+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.